...is approved in Canada as Tretten catridecacog; in the EU, Switzerland and Australia as NovoThirteen catridecacog...
...catridecacog; in the EU, Switzerland and Australia as NovoThirteen catridecacog; and in the U.S. as Tretten...
...Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Product: NovoThirteen catridecacog ( Tretten ), recombinant coagulation Factor XIII A-subunit ( rFXIII...

...Hemophilia A U.S. Novo Nordisk A/S (CSE:NVO; NYSE:NVO)/Bristol-Myers Squibb Co. (NYSE:BMY) Tretten recombinant coagulation Factor XIII A-subunit (Tretten catridecacog, NovoThirteen...

...in adults and children Novo Nordisk A/S (CSE:NVO; NYSE:NVO)/Bristol-Myers Squibb Co. (NYSE:BMY) FDA approves Tretten recombinant coagulation Factor XIII A-subunit...

...On Dec. 23, 2013, FDA approved a resubmitted BLA from Novo Nordisk for Tretten recombinant coagulation Factor XIII A-subunit to...
...approved in Canada as Tretten catridecacog and in the EU, Switzerland and Australia as NovoThirteen catridecacog...
...Denmark Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Product: Tretten recombinant coagulation Factor XIII A-subunit ( NovoThirteen catridecacog) ( rFXIII...

...FDA approved a resubmitted BLA from Novo Nordisk A/S (CSE:NVO; NYSE:NVO) for Tretten cartridecacog to prevent...
...A-subunit is approved in Canada as Tretten and in the EU, Switzerland and Australia as NovoThirteen...

...disclosed that last month it resubmitted a BLA to FDA for NovoThirteen recombinant factor XIII (rFXIII...

...disclosed that this month it resubmitted a BLA to FDA for recombinant factor XIII ( rFXIII...

...received a second complete response letter from FDA for a BLA for recombinant factor XIII (rFXIII...
...Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Product: rFXIII...

...June a second complete response letter from FDA for a BLA for recombinant factor XIII (rFXIII...

...a second complete response letter from FDA for a BLA for recombinant factor XIII ( rFXIII...